| Budget Amount *help |
¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
|---|
| Research Abstract |
Oral Squamous Cell Carcinoma (OSCC) is in serious disease patient quality of life and life-threatening. In the treatment of oral Squamous Cell Carcinoma (OSCC), operative therapy and chemotherapy-radiation x-ray, and greatly contributed to improve the survival rate of patients with cancer and recurrences. But distant metastasis suppressor is difficult in the current development of a new treatment is desired. Applicant transplant, oral Squamous Cell Carcinoma (OSCC) cell line in nude mice and the successful establishment of the and create a model from a high metastatic spread to the lung. And micro-array analysis, discovery and identification as a candidate gene admitted Angptl4 (angiopoietin-like protein 4) upswing.
|
